Trial Profile
Modulation of the Brain Excitatory/Inhibitory (E/I) Balance Through Neuronal Systems in Autism Spectrum Disorder (ASD)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2023
Price :
$35
*
At a glance
- Drugs AZD 7325 (Primary)
- Indications Pervasive child development disorders
- Focus Pharmacodynamics
- 14 Apr 2022 Planned End Date changed from 14 Sep 2021 to 26 Aug 2023.
- 14 Apr 2022 Planned primary completion date changed from 15 Feb 2020 to 15 Feb 2023.
- 14 Apr 2022 Status changed from recruiting to active, no longer recruiting.